Methyl 3-amino-5-bromo-4-methylbenzoate(CAS: 223519-11-7)

Methyl 3-amino-5-bromo-4-methylbenzoate (CAS: 223519-11-7) falls under the scope of various regulatory guidelines. It is classified according to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS). For production and distribution, it must comply with REACH regulations for identifying and managing the risks associated with its use. Additionally, the FDA and EPA have specific requirements for handling and disposing of this chemical to ensure public and environmental safety.

In the synthesis of similar compounds, there are several alternatives to Methyl 3-amino-5-bromo-4-methylbenzoate (CAS: 223519-11-7). These include methyl 3-amino-4-methylbenzoate and methyl 5-bromo-4-methylbenzoate, which can serve as viable substitutes. Other alternative reagents might include bromobenzene or similar aromatic compounds, depending on the specific desired properties of the final product.

The market for Methyl 3-amino-5-bromo-4-methylbenzoate (CAS: 223519-11-7) is driven by its applications in pharmaceuticals and research. Recent trends indicate growing interest in its use as an intermediate in drug synthesis and as a component in research studies focused on chemical biology and medicinal chemistry. The demand is likely to increase with advancements in these fields and the development of new applications.

Waste containing Methyl 3-amino-5-bromo-4-methylbenzoate (CAS: 223519-11-7) should be collected in appropriate containers and stored separately to prevent contamination. Professional waste disposal services should be used to ensure proper incineration or other environmentally safe disposal methods. Environmental protection precautions should include the use of personal protective equipment and adherence to local and national waste management regulations to minimize environmental impact.